144 related articles for article (PubMed ID: 23831411)
21. Repeated intranigral MPTP administration: a new protocol of prolonged locomotor impairment mimicking Parkinson's disease.
Reksidler AB; Lima MM; Dombrowski P; Andersen ML; Zanata SM; Andreatini R; Tufik S; Vital MA
J Neurosci Methods; 2008 Jan; 167(2):268-77. PubMed ID: 17931705
[TBL] [Abstract][Full Text] [Related]
22. Memory impairment induced by low doses of reserpine in rats: possible relationship with emotional processing deficits in Parkinson disease.
Fernandes VS; Ribeiro AM; Melo TG; Godinho M; Barbosa FF; Medeiros DS; Munguba H; Silva RH
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1479-83. PubMed ID: 18579275
[TBL] [Abstract][Full Text] [Related]
23. Effects of MK-801 on recognition and neurodegeneration in an MPTP-induced Parkinson's rat model.
Hsieh MH; Gu SL; Ho SC; Pawlak CR; Lin CL; Ho YJ; Lai TJ; Wu FY
Behav Brain Res; 2012 Apr; 229(1):41-7. PubMed ID: 22227506
[TBL] [Abstract][Full Text] [Related]
24. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.
Yuan H; Sarre S; Ebinger G; Michotte Y
J Neurosci Methods; 2005 May; 144(1):35-45. PubMed ID: 15848237
[TBL] [Abstract][Full Text] [Related]
25. Neuroinflammation in early, late and recovery stages in a progressive parkinsonism model in rats.
Cunha DMG; Becegato M; Meurer YSR; Lima AC; Gonçalves N; Bioni VS; Engi SA; Bianchi PC; Cruz FC; Santos JR; Silva RH
Front Neurosci; 2022; 16():923957. PubMed ID: 36090265
[TBL] [Abstract][Full Text] [Related]
26. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ
Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250
[TBL] [Abstract][Full Text] [Related]
27. Testosterone propionate improves motor alterations and dopaminergic damage in the reserpine-induced progressive model of Parkinson's disease.
Bispo JMM; Melo JEC; Gois AM; Medeiros KAAL; Silva RS; Leal PC; Franco HS; Souza MF; Lins LCRF; Ribeiro AM; Silva RH; Santos JR
Brain Res Bull; 2022 Sep; 187():162-168. PubMed ID: 35781030
[TBL] [Abstract][Full Text] [Related]
28. Deltamethrin Intranasal administration induces memory, emotional and tyrosine hydroxylase immunoreactivity alterations in rats.
Souza MF; Freire MAM; Medeiros KAAL; Lins LCRF; Bispo JMM; Gois AM; Leal PC; Engelberth RCGJ; Ribeiro AM; Silva RH; Marchioro M; Santos JR
Brain Res Bull; 2018 Sep; 142():297-303. PubMed ID: 30118749
[TBL] [Abstract][Full Text] [Related]
29. Further characterisation of the LPS model of Parkinson's disease: a comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat.
Hoban DB; Connaughton E; Connaughton C; Hogan G; Thornton C; Mulcahy P; Moloney TC; Dowd E
Brain Behav Immun; 2013 Jan; 27(1):91-100. PubMed ID: 23044176
[TBL] [Abstract][Full Text] [Related]
30. An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate.
Fleming SM; Delville Y; Schallert T
Behav Brain Res; 2005 Jan; 156(2):201-13. PubMed ID: 15582106
[TBL] [Abstract][Full Text] [Related]
31. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
[TBL] [Abstract][Full Text] [Related]
32. Reversal of reserpine-induced orofacial dyskinesia and cognitive dysfunction by quercetin.
Naidu PS; Singh A; Kulkarni SK
Pharmacology; 2004 Feb; 70(2):59-67. PubMed ID: 14685008
[TBL] [Abstract][Full Text] [Related]
33. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
[TBL] [Abstract][Full Text] [Related]
34. Contribution of the mGluR7 receptor to antiparkinsonian-like effects in rats: a behavioral study with the selective agonist AMN082.
Konieczny J; Lenda T
Pharmacol Rep; 2013; 65(5):1194-203. PubMed ID: 24399715
[TBL] [Abstract][Full Text] [Related]
35. A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery.
Mounayar S; Boulet S; Tandé D; Jan C; Pessiglione M; Hirsch EC; Féger J; Savasta M; François C; Tremblay L
Brain; 2007 Nov; 130(Pt 11):2898-914. PubMed ID: 17855373
[TBL] [Abstract][Full Text] [Related]
36. Exercise exerts neuroprotective effects on Parkinson's disease model of rats.
Tajiri N; Yasuhara T; Shingo T; Kondo A; Yuan W; Kadota T; Wang F; Baba T; Tayra JT; Morimoto T; Jing M; Kikuchi Y; Kuramoto S; Agari T; Miyoshi Y; Fujino H; Obata F; Takeda I; Furuta T; Date I
Brain Res; 2010 Jan; 1310():200-7. PubMed ID: 19900418
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of a small, unilateral, 6-hydroxydopamine-induced nigral lesion on behavior in high and low responders to novelty.
van Oosten RV; Cools AR
Exp Neurol; 2002 Feb; 173(2):245-55. PubMed ID: 11822888
[TBL] [Abstract][Full Text] [Related]
38. Intracerebroventricular injection of deltamethrin increases locomotion activity and causes spatial working memory and dopaminergic pathway impairment in rats.
Souza MF; Medeiros KAAL; Lins LCRF; Bispo JMM; Gois AM; Freire MAM; Marchioro M; Santos JR
Brain Res Bull; 2020 Jan; 154():1-8. PubMed ID: 31606407
[TBL] [Abstract][Full Text] [Related]
39. Reduced expression of choline acetyltransferase in vagal motoneurons and gastric motor dysfunction in a 6-OHDA rat model of Parkinson's disease.
Zheng LF; Wang ZY; Li XF; Song J; Hong F; Lian H; Wang Q; Feng XY; Tang YY; Zhang Y; Zhu JX
Brain Res; 2011 Oct; 1420():59-67. PubMed ID: 21955729
[TBL] [Abstract][Full Text] [Related]
40. A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area.
Xavier LL; Viola GG; Ferraz AC; Da Cunha C; Deonizio JM; Netto CA; Achaval M
Brain Res Brain Res Protoc; 2005 Dec; 16(1-3):58-64. PubMed ID: 16310404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
